BARCELONA – Dr. Ann Marie Navar-Boggan has a beef with current American and European cholesterol guidelines, which she believes seriously underestimate the long-term adverse impact of hypercholesterolemia in younger adults.
Here are the data Dr. Navar-Boggan of the Duke Clinical Research Institute, Durham, N.C., presented at the annual congress of the European Society of Cardiology to bolster her argument for more aggressive treatment of hypercholesterolemia in this population.